Sugammadex
- Generic Name
- Sugammadex
- Brand Names
- Bridion, Sugammadex Adroiq, Sugammadex Amomed, Sugammadex Fresenius Kabi, Sugammadex Mylan, Sugammadex Piramal
- Drug Type
- Small Molecule
- Chemical Formula
- C72H112O48S8
- CAS Number
- 343306-71-8
- Unique Ingredient Identifier
- 361LPM2T56
- Background
Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery. Rocuronium bromide and vecuronium bromide are neuromuscular blocking medications that cause temporary paralysis and are especially useful for general anesthesia, ventilation, or tracheal intuba...
- Indication
Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide or vecuronium bromide in adults and pediatric patients ≥2 years old who are undergoing surgery.
- Associated Conditions
- Neuromuscular blockade caused by vecuronium bromide
- Associated Therapies
- -
Sugammadex on Laparoscopic Bariatric Surgery
- Conditions
- Interventions
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Shanxi Bethune Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06678451
Placental Transfer of Sugammadex in the Human Placental Perfusion Model
- First Posted Date
- 2024-10-09
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Target Recruit Count
- 16
- Registration Number
- NCT06634355
- Locations
- 🇧🇪
UZ Leuven, Leuven, Vlaams-Brabant, Belgium
Sugammadex and Time to Extubation in Ophthalmic Surgery
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 262
- Registration Number
- NCT06632067
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
Sugammadex Dose Finding Under Two Years Old
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Sang-Hwan Ji
- Target Recruit Count
- 33
- Registration Number
- NCT06575036
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis
- Conditions
- Interventions
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Beijing Tongren Hospital
- Target Recruit Count
- 64
- Registration Number
- NCT06436768
- Locations
- 🇨🇳
Beijing tongren Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China
Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients
- Conditions
- Interventions
- First Posted Date
- 2024-01-29
- Last Posted Date
- 2024-01-29
- Lead Sponsor
- Matias Vested
- Target Recruit Count
- 40
- Registration Number
- NCT06228092
- Locations
- 🇩🇰
Department of anaesthesia, Centre of Head and Orthopedics, Rigshospitalet, Copenhagen, Denmark
🇩🇰Bispebjerg Hospital, Copenhagen, Denmark
🇩🇰Department of Pediatric and Obstetric Anaesthesia, Rigshospitalet, Copenhagen, Denmark
Muscle Relaxation for Pediatric Adenotonsillectomy
- Conditions
- Interventions
- First Posted Date
- 2024-01-26
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 172
- Registration Number
- NCT06225466
- Locations
- 🇺🇸
Children's Health Dallas, Dallas, Texas, United States
Effects of Sugammadex and Conventional Reversal on Lung Function in Laparoscopic Abdominal Surgery
- Conditions
- Interventions
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Rhendra Hardy Mohamad Zaini
- Target Recruit Count
- 80
- Registration Number
- NCT06210165
- Locations
- 🇲🇾
University of Science Malaysia Hospital, Kubang Kerian, Kelantan, Malaysia
Neostigmine Versus Sugammadex on Renal Functions
- Conditions
- Interventions
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- Menoufia University
- Target Recruit Count
- 64
- Registration Number
- NCT06081738
- Locations
- 🇪🇬
Menoufia University Hospitals, Shibīn Al Kawm, Menoufia, Egypt
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
- Conditions
- Interventions
- First Posted Date
- 2023-08-15
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05993390
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.